bluebird bio Inc. (BLUE) Fundamentals

bluebird bio Inc is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.
SHARE INFORMATION
Market Cap$ 439,593,981
Shares Outstanding77,121,751
Float56,248,988
Percent Float72.94%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 3,662,000
Latest Fiscal EPS$ -11.89
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions459
Institutional Holdings Date2022-08-31
Institutional Bought Previous 3 Months14,504,040
Institutional Holdings Percent122.1%
Institutional Sold Previous 3 Months44,599,966
Insider Holdings Date2022-08-31
Insider Bought Previous 3 Months51,898
Insider Holdings Percent1.9
Insider Sold Previous 3 Months70,200
Insider Shares Owned1,473,483
TRADING INFO
52 Week High$ 25.39
52 Week Low$ 2.87
52 Week High Change$ -69.97
21 Day Moving Average$ 6.3681
21 Day Extended Moving Average$ 6.0775
50 Day Moving Average$ 5.8382
50 Day Extended Moving Average$ 5.832
200 Day Moving Average$ 5.7042
200 Day Extended Moving Average$ 8.0579
10 Day Average Volume12,189,871
20 Day Average Volume9,472,318
30 Day Average Volume9,405,452
50 Day Average Volume8,675,543
Alpha-0.043942
Beta1.1643
Standard Deviation0.173600
R20.114526
7 Day Price Change$ -0.27
7 Day Percent Change-4.52%
21 Day Price Change$ -1.41
21 Day Percent Change-19.83%
30 Day Price Change$ -0.20
30 Day Percent Change-3.39%
Month to Date Price Change$ -0.14
Month to Date Percent Change-2.4%
Quarter to Date Price Change$ 1.56
Quarter to Date Percent Change37.68%
180 Day Price Change$ 0.50
180 Day Percent Change9.62%
200 Day Price Change$ 1.32
200 Day Percent Change30.14%
Year to Date Price Change$ -4.29
Year to Date Percent Change-42.94%

bluebird bio Inc. (BLUE) Key Ratios

PROFITABILITY
EBIT Margin-7,972.1%
EBITDA Margin-7,797.1%
Pre-Tax Profit Margin-2,442.7%
Profit Margin Count0.0%
Gross Margin-580.8%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ -13,140,000
Revenue Per Share$ -0.1704
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.60
Total Debt To Equity1.60
Int Coverage0.00
Current Ratio1.10
Leverage Ratio1.80
Quick Ratio1.00
Long Term Debt To Capital0.58
VALUATION MEASURES
PE Ratio-0.70
Enterprise Value$ 605,451,503
Price to Sales-33.4546
Price to Free Cash-0.80
PE High Last 5 Years-3.50
Price To Book2.50
Price To Cash Flow5.70
PE Low Last 5 Years-7.30
Price to Tangible Book2.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover-1.70
Invoice Turnover5.60
Assets Turnover0.00
Return Assets-63.93
Return on Equity-113.16
Return on Capital-71.82

bluebird bio Inc. (BLUE) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOAndrew Obenshain
Emplyoees518
Last AuditUE
CIK0001293971
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address60 Binney Street
Cambridge, MA 2142
Websitehttps://www.bluebirdbio.com
Facsimile-
Telephone+1 339 499-9300
EmailIGoldberg@bluebirdbio.com


Your Recent History
NASDAQ
BLUE
bluebird b..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.